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Abstract
Water soluble β-carotene (WS-BC) is a carotenoid form that has been developed as a food
colorant. WS-BC is known to contain 10% of all-trans β-carotene (AT-BC). The aim of the present
study was to investigate in vivo tissue uptake of AT-BC after the administration of WS-BC into rats.
Seven-week-old male rats were administered 20 mg of WS-BC dissolved in saline by intravenous
injection into the tail vein. At 0, 6, 24, 72, 120 and 168 hours (n = 7/time), blood was drawn and
liver, lungs, adrenal glands, kidneys and testes were dissected. The levels of AT-BC in the plasma
and dissected tissues were quantified with HPLC. After intravenous administration, AT-BC level in
plasma first increased up to 6 h and returned to normal at 72 h. In the testes, the AT-BC level first
increased up to 24 h and then did not decrease but was retained up to 168 h. In the other tissues,
the level first increased up to 6 h and then decreased from 6 to 120 or 168 h but did not return to
normal. The accumulation of WS-BC in testes but not in the other 5 tissues examined may suggest
that AT-BC was excreted or metabolized in these tissues but not in testes. Although WS-BC is
commonly used as a food colorant, its effects on body tissues are still not clarified. Results of the
present study suggest that further investigations are required to elucidate effects of WS-BC on
various body tissues.
Findings
Carotenoids are one of the main groups of coloring sub-
stances in nature [1-3]. The advantages to add carotenoids
as food colorants are: high tinctorial potency, safety, sta-
bility, compatibility and availability. As color conveys a
concept of freshness and wholesomeness by an ingrained
color-taste expectancy relationship, the technical chal-
lenge of the food industry has been to create suitable
application forms of carotenoids for food coloring needs
[1-4]. Several application forms of the carotenoids have
been developed for coloring both fat-based (margarine,
cheese, butter, etc.) and water-based (juice, beverages,
etc.) foods [4]. Because carotenoids are fat soluble, three
approaches were used to overcome this disadvantage: 1)
reduction in crystal size; 2) preparation of emulsions in
liquid and beadlet forms; and 3) development of colloi-
dal preparations [4]. Since various application forms of β-
carotene have been developed and are most widely used
as food colorants, people intake β-carotene easily in their
daily life. β-Carotene is one of the provitamin A caroten-
oids, which is cleaved to retinal, followed by its conver-
sion to retinyl ester within the small intestine [5-8].
Vitamin A and its analogs (retinoids) are needed to main-
tain normal growth and development, immunity, repro-
duction and other essential physiologic processes [8-10].
Besides the provitamin A activity, β-carotene has other
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important biological functions such as quenching of sin-
glet oxygen, interrupting peroxidation, reducing the free
radicals and so on [3,6]. Many epidemiological studies
over a long period have reported a negative relationship
between β-carotene intake and chronic disease [reviewed
in [6,11]]. However, two large recent trials found that
pharmacological levels of β-carotene increased lung can-
cer incidence and deaths in smokers [12,13] and asbestos
workers [13]. A larger trial with healthy American men,
however, found no effect of β-carotene on several types of
malignant neoplasms except an increased risk for thyroid
and bladder cancer [14]. These contradictory reports
[6,11-14] suggest a possible dual response of β-carotene,
whereby it promotes health when taken at dietary levels,
but may have adverse effects when taken at higher doses
[15]. The tissue distribution of β-carotene is still not
clearly defined [15]. In the present study, we aimed to
examine rat in vivo tissue uptake of all-trans β-carotene
(AT-BC). The studies of β-carotene distribution are diffi-
cult because several factors, such as the solubility condi-
tions and in vivo digestion, influence its absorption.
Therefore, the choice of solvent and the method of β-car-
otene administration have been controversial [16]. In the
present study, we used water soluble β-carotene (WS-BC)
which has been commonly used as one of the application
forms of food colorants. The WS-BC is considered to over-
come the β-carotene insolubility and its absorption diffi-
culties.
Dry  β-carotene beadlets (Trade name: Dry β-Carotene
10% Cold Water-Soluble) were kindly donated by Hoff-
mann La Roche Japan, Co., Ltd. (Tokyo, Japan). The
beadlets contained 10% of AT-BC. In addition, the
beadlets consisted of vehicle (starch, gelatin, sucrose and
plant oil) and antioxidants (vitamin E and vitamin C). In
this paper, the dry β-carotene beadlets refer to as water sol-
uble β-carotene (WS-BC). The reagents used were pur-
chased from Wako Pure Chemical Industries Inc. (Osaka,
Japan). The solvents for high performance liquid chroma-
tography (HPLC) were purchased from Nacalai Tesque
Inc. (Kyoto, Japan). Sprague-Dawley male rats (7 weeks
old, body weight 210-230 g) were purchased from CLEA
Japan, Inc. (Tokyo, Japan) and housed under constant
temperature on a 12-hour light/dark cycle. Before the
intravenous injection of WS-BC, rats were fed standard
laboratory diet (CE-2, CLEA Japan, Inc., Tokyo, Japan)
and given access to tap water ad libitum for 5 days. To
make WS-BC solution, 20 mg of WS-BC was dissolved in
saline, and 1 ml of this solution was injected into the tail
vein of the rat. Thus, the actual amount of AT-BC admin-
istered into the rat was 2 mg. The intravenous injection of
WS-BC was performed as described previously [16]. At 0,
6, 24, 72, 120 and 168 hours after the intravenous admin-
istration of WS-BC, blood was drawn from the abdominal
vein and centrifuged to obtain plasma. Rats were sacri-
ficed, and liver, lungs, adrenal glands, kidneys and testes
were removed and frozen in liquid nitrogen. For each time
point, 7 rats were used. The removed organs and plasma
were kept at -80°C until further analysis. All experimental
protocols were conducted in accordance with Japanese Act
on Welfare and Management of Animals (Act No. 105 of
October 1, 1973). The quantification of AT-BC in the tis-
sues was performed using HPLC as described before [16].
Data were presented as means ± SD. Statistical analyses
were carried out using Origin (Microcal Software Inc.,
USA) or Excel (Microsoft, USA) software. Differences were
considered significant at the level of p < 0.05.
The mean (± SD) AT-BC levels in the tissues were exam-
ined at 6 time points after the intravenous administration
(Figure 1). The AT-BC levels in all tissues increased up to
6 h (Figure 1). From this, it may be assumed that the AT-
BC circulated in the blood stream and was distributed to
these tissues within 6 h. In plasma, the AT-BC level
decreased rapidly after 6 h and the level at 72 h was not
significantly different from that at 0 h (Figure 1A). This
may suggest that all the AT-BC administered in plasma
was distributed to other body tissues or excreted from
blood by 72 h. The AT-BC level in the liver decreased over
a period of 6 h to 120 h (Figure 1B). In the lung, adrenal
gland and kidney, the AT-BC levels decreased gradually
from 6 h to 120 or 168 h (Figure 1C, D and 1E). This may
indicate that the AT-BC was excreted from these tissues or
was metabolized to the possible metabolites of AT-BC,
retinoids and carotenoid isomers [5-8,15]. The AT-BC lev-
els in lung, adrenal gland and kidney at 120 and/or 168 h
were still significantly different from those at 0 h (Figure
1C, D and 1E). This observation could suggest that some
amount of AT-BC was still retained at 120 or 168 h in
these tissues. In the testes, AT-BC level first increased up to
24 h and then did not decrease but was retained up to 168
h (Figure 1F).
In the present study, in vivo tissue uptake of AT-BC was
examined after the intravenous administration of WS-BC
into rats. The in vivo emulsifying conditions have been
shown to affect β-carotene absorption [15,17]. In our
pilot experiments, when the rats were fed a refined diet
containing WS-BC, the level of AT-BC in serum, liver and
lung showed a wide variation between animals (data not
shown). This may suggest that in vivo tissue uptake of AT-
BC is affected by individual absorption conditions of WS-
BC. Therefore, oral administration of WS-BC is considered
difficult to examine in vivo tissue uptake. Furthermore, in
our previous work involving intravenous administration
of the emulsified AT-BC crystals in solvent, high levels of
AT-BC accumulated in the lung [16]. This was suggested to
be due to the trapping of the solvent used for dissolving
AT-BC [16]. To overcome these problems of absorption
and insolubility of AT-BC, in the present study, WS-BCNutrition Journal 2009, 8:56 http://www.nutritionj.com/content/8/1/56
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Time dependent changes in AT-BC levels in 6 tissues after WS-BC intravenous administration in rat Figure 1
Time dependent changes in AT-BC levels in 6 tissues after WS-BC intravenous administration in rat. Values 
plotted are mean ± SD (n = 7/time). For each tissue, individual AT-BC values at each time point were adjusted by subtracting 
the respective mean values at 0 hour, and mean ± SD were then calculated. * significantly different as compared with AT-BC 
level at 0 h. # significantly different as compared with AT-BC level at the preceding time point.
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was dissolved in saline and administered intravenously.
However, like our previous study [16], in some tissues
including lung, accumulation of a large amount of AT-BC
was not found in the present study. This would suggest
that the WS-BC was not trapped by the solvent in the
present study whereas it was in the previous study [16].
The antioxidant properties of β-carotene are strictly
dependent on oxygen partial pressure (OPP) [18,19]. In
vitro  experiments at different OPP have demonstrated
ambiguous behavior of β-carotene [18]. At OPP less than
the oxygen pressure in normal air, β-carotene behaved as
an antioxidant whereas at higher values, it was found to
lose its antioxidant activity and actually showed a pro-oxi-
dant effect [18]. A number of reports have now confirmed
this phenomenon in purified systems [20], microsomes
[21], cell lines [22] and bacteria [23]. In addition, after β-
carotene administration to rats, cytochrome P450 iso-
forms were induced and reactive oxygen species (ROS)
were increased in kidney, lung, intestine and liver, with
liver being the most affected tissue [19]. From these find-
ings, it was suggested that β-carotene may have two con-
tradicting behaviors, antioxidant and pro-oxidant [19].
Oxidative stress plays a major contributory role in patho-
genesis of many generative and chronic diseases [19].
Many epidemiological studies have been reported which
show a negative relationship between dietary β-carotene
intake and chronic disease [6,11]. On the other hand,
recent intervention trials suggest that β-carotene supple-
mentation may promote health when taken at dietary lev-
els but have adverse effects when taken in higher amounts
[11,15]. The conflicting behavior of β-carotene may
explain why the contradictory results were obtained in dif-
ferent studies.
In the present study, the observation of accumulation of
AT-BC over a period of 168 h after the intravenous admin-
istration of WS-BC (Figure 1F) suggests that under certain
conditions, testes may have the ability to store AT-BC for
several days. In an immunohistochemical study [7],
human  β-carotene 15,15'-mono-oxygenease (BCO1),
which is involved in the symmetrical cleavage of β-caro-
tene into two retinal molecules, was detected in steroidog-
enic cells in testis, ovary, and adrenal gland [24]. The level
of mRNA of carotene cleavage enzyme (CCE), which
cleaves provitamin A carotenoid to retinol, was found to
be highest in testis among 4 tissues examined including
the small intestine [8]. From these observations, it was
suggested that in testis, β-carotene could act as a local
source of retinoids, which have been shown to be impor-
tant during proliferation, differentiation, and maturation
of germinal cells [7,8,24]. In male rats treated with fenva-
lerate [25] or cadmium [26], administration of β-carotene
was reported to ameliorate the induced toxicity in the tes-
tis. Moreover, β-carotene administration increased semen
quality [25]. Overall, from these findings, it appears that
β-carotene may be essential for the function of testes.
Because β-carotene is commonly used commercially to
color food, people intake it easily in their daily life. Since
this provitamin has an ambiguous behavior as becoming
antioxidant or pro-oxidant depending on its partial oxy-
gen pressure, results of the present study suggest that fur-
ther investigations are required to elucidate its effect on
body tissues under various physiological conditions.
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